Effect of Nimodipine on Regional Cerebral Glucose Metabolism in Patients with Acute Ischemic Stroke as Measured by Positron Emission Tomography.


Phase N/A Results


The Barthel Index at the end of treatment was lower in the nimodipine group but the difference was not significant. The nimodipine group, however showed the larger trend toward subsequent improvement. No significant differences were found in Mathew Scores. The two groups were similar in their initial metabolic depression as measured by FDG PET but glucose metabolism in non-infarcted regions increased more in the nimodipine than in the control group.